APA

Meehan K. R., Verma U. N., Cahill R., Frankel S., Areman E. M., Sacher R. A., Foelber R., Rajagopal C., Gehan E. A., Lippman M. E. & Mazumder A. (19980123). Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates. : Bone marrow transplantation.

Chicago

Meehan K R, Verma U N, Cahill R, Frankel S, Areman E M, Sacher R A, Foelber R, Rajagopal C, Gehan E A, Lippman M E and Mazumder A. 19980123. Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates. : Bone marrow transplantation.

Harvard

Meehan K. R., Verma U. N., Cahill R., Frankel S., Areman E. M., Sacher R. A., Foelber R., Rajagopal C., Gehan E. A., Lippman M. E. and Mazumder A. (19980123). Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates. : Bone marrow transplantation.

MLA

Meehan K R, Verma U N, Cahill R, Frankel S, Areman E M, Sacher R A, Foelber R, Rajagopal C, Gehan E A, Lippman M E and Mazumder A. Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates. : Bone marrow transplantation. 19980123.